Riyadh - Sharikat Mubasher: DawaDose, a Riyadh-headquartered integrated pharmaceutical platform, successfully closed an undisclosed seed funding round to fuel its new phase of regional growth.
DawaDose will use the new investment to strengthen its presence in Saudi Arabia and Jordan and accelerate its expansion into Oman and Kuwait, the company revealed in an official statement yesterday.
The company prepares to raise a pre-Series A in the next period to scale operations, expand strategic partnerships, and solidify its presence in the region.
In September 2025, DawaDose closed a pre-seed round from several angel investors to fuel its expansion in Saudi Arabia by establishing a new headquarters in Riyadh.
DawaDose is the first fully integrated pharmaceutical ecosystem in the Middle East, connecting pharmacies, pharmaceutical companies, drugstores, and consumers through one intelligent platform. It empowers the entire pharmaceutical value chain, from online pharmacy access for everyday consumers to a digital marketplace that connects wholesalers and pharmacies.